Solid phase synthesis of benzylamine-derived sulfonamide library

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 7, 1998, Pages 735-738

  Kim, Sang Woong ^a   Hong, Chang Yong ^a   Lee, Koo ^a   Lee, Eun Ju ^a,b   Koh, Jong Sung ^a  

^a LG Chemical Ltd   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLAMINE DERIVATIVE; SULFONAMIDE; THROMBIN INHIBITOR;

ARTICLE; DRUG PURITY; DRUG SYNTHESIS; LIBRARY; REACTION ANALYSIS;

ANTICOAGULANTS; BENZYLAMINES; DRUG DESIGN; INDICATORS AND REAGENTS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; THROMBIN;

EID: 0032492707     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00114-0     Document Type: Article

References (26)

1. 1. (a) Edmunds, J.J.; Rapundalo, S.T. Annu. Rep. Med. Chem. 1996, 31, 51.
2. (b) Stone, S.R. Trends Cardiovasc. Med. 1995, 5, 134.
3. (c) Tapparelli, C.; Metternich, R.; Ehrhardty, C.; Cook, N.S. Trends Pharm. Sci. 1993, 366.
4. 2. See the leading reviews; (a) Lam, K.S.; Lebl, M.; Krehnak, V. Chem. Rev. 1997, 97, 411.
5. (b) Gallop, M.A.; Barrett, R.W.; Dower, W. J.; Fodor, S.P.A.; Gordon, E.M J. Med Chem. 1994, 37, 1233.
6. (c) Thompson, L.A.; Ellman, J.A. Chem. Rev. 1996, 96, 555.
7. (d) Nefzi, A.; Ostresh, J.M.; Houghten, R A. Chem. Rev. 1997, 97, 449.
8. (e) Gordon, E.M.; Barrett, R.W.; Dower, W.J., Fodor, S.P.A.; Gallop, M A. J. Med. Chem. 1994, 37, 1385.
9. (f) Desai, M.C.; Zuckermann, R.N.; Moos, W H. Drug Development Research 1994, 33, 174
10. (g) Terrett, N.K.; Gardner, M.; Gordon, D.W.; Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135.
11. (h) Balkenhohl, F.; Bussche-Hunnefeld, C.V.D.; Lansky, A.; Zechel, C. Angew. Chem. Int. Ed. Engl. 1996, 35, 2288.
12. (i) Still, W.C. Acc. Chem. Res. 1996, 29, 155.
13. (j) Jung, G.; Beck-Sickinger, A.G. Angew Chem. Int. Ed. Engl. 1992, 31, 367.
14. 3. (a) Plunket, M.J.; Ellman, J.A. J. Am. Chem. Soc. 1995, 117, 3306.
15. (b) Boojamra, C.G.; Burow, K.M.; Thompson, L.A.; Ellman, J.A. J. Org. Chem. 1997, 62, 1240.
16. (c) Buckman, B.O., Mohan, R. Tetrahedron Lett. 1996, 37, 4439.
17. (d) Kim, S.W.; Ahn, S.Y.; Koh, J.S.; Lee, J.H.; Ro, S.; Cho, H.Y. Tetrahedron Lett. 1997, 38, 4603.
18. (e) DeWitt, S.H.; Kiley, H.S.; Stankovic, C.J.; Schroeder, M.C.; Cody, D.M.R.; Pavia, M.R. Proc. Natl. Acad Sci. USA, 1993, 90, 6909.
19. 4. Furth, P.S.; Reitman, M.S.; Cook, A.F. Tetrahedron Lett. 1997, 38, 5403.
20. 5. (a) Roussel, P.; Bradley, M.; Matthews, I., Kane, P. Tetrahedron Lett. 1997, 38, 4861
21. (b) Kim, S.W.; Hong, C.Y., Lee, E. J.; Lee, K. Molecular Diversity, 1998 in press.
22. 6. (a) Wang, S.S. J. Am. Chem. Soc. 1973, 95, 1328.
23. (b) Wang resin (0.85mmol/g) was purchased from Advanced ChemTech
24. 7. (a) Oh, Y.S., Kim, S.S.; Hwang, S.Y.; Yun, M.K.; Hwang, S.R.; Hong, S.W.; Lee, Y.H.; Jeong, Y.N ; Lee, K.; , Shin, Y. S. European Patent Application EP739886-A2, 1996, Chem. Abstr. 1996, 126, 47554.
25. (b) Kim, S.; Hwang, S.Y.; Kim, Y.K.; Yun, M.K.; Oh, Y.S. Bioorg. Med. Chem. Lett. 1997, 7 769.
26. 8. Sturzebecher, J.; Vieweg, H.; Wikstroem, P.; Alder, C. patent WO 94/18185.